STADA Arzneimittel AG: Information on financing of the Takeover Offer

DGAP-News: STADA Arzneimittel AG / Key word(s): Miscellaneous STADA Arzneimittel AG: Information on financing of the Takeover Offer 15.09.2017 / 11:28 The issuer is solely responsible for the content of this announcement. Bad Vilbel, September 15, 2017 - In the context of financing of the takeover offer of Nidda Healthcare Holding AG, the acquiring company of Bain Capital and Cinven, STADA Arzneimittel AG today published on its website under www.stada.com/additional-financial-information a report referred to as "Information Release". Contact: STADA Arzneimittel AG / Investor Relations / Leslie Iltgen / Stadastraße 2-18 / 61118 Bad Vilbel - Germany / Tel.: [phone] / Fax: [phone] / E-mail: [e-mail] Or visit us in the Internet at www.stada.com. 15.09.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	STADA Arzneimittel AG
	Stadastraße 2-18
	61118 Bad Vilbel
	Germany
Phone:	[phone]
Fax:	[phone]
E-mail:	[e-mail]
Internet:	www.stada.de
ISIN:	DE0007251803, DE0007251845,
WKN:	725180, 725184,
Indices:	MDAX
Listed:	Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange

End of News	DGAP News Service

610047  15.09.2017